Tenderwize
Back to tender search

Supply of asfotase alfa

Uniwersytecki Dziecięcy Szpital Kliniczny im. L. Zamenhofa w Białymstoku·Białystok, Poland·Expired · Aug 18, 2026·Open·Supplies
Sign up to saveOpen documents
Original notice title

Poland – Various medicinal products – DOSTAWA ASFOTAZY ALFA

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesExpired
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...

Strict pharmaceutical licensing requirements; winner must provide license within 10 days

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration 24 MONTH
  • Supply of asfotase alfa injection solution (40 mg/ml) in three pack sizes: 0.45 ml (160 packs), 0.7 ml (30 packs), 1.0 ml (60 packs)
  • Delivery to University Children's Clinical Hospital in Białystok, Poland
Show full summary

Open tender for the supply of asfotase alfa (asfotazy alfa) to a children's hospital in Białystok, Poland. Single lot, 24-month contract. Award based solely on lowest price. No estimated value published, but a high bid bond (252,456 PLN) is required. The buyer is a public hospital. EU funding status is inconsistent between structured data (EU-funded) and notice (no EU funds). Eligibility includes pharmaceutical licenses. Only Polish language is accepted.

Risks

Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...

Strict pharmaceutical licensing requirements; winner must provide license within 10 days

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Bid bond (wadium) of 252,456 PLN required before deadline

Administrative

  • Submission via e-ProPublico platform only
  • Offer must be signed with qualified electronic signature

Award Criteria

Lot 1

Price (100%) - lowest price wins — 100%

Buyer

Location

Białystok, POL

Buyer profile

Open profile

Identifier

542-25-34-063

Activity

Health

Lots (1)

LOT-0001

Supply of asfotase alfa

Delivery of asfotase alfa injection solution in three pack sizes: 40 mg/ml 0.45 ml (160 packs), 0.7 ml (30 packs), and 1.0 ml (60 packs) over 24 months to the University Children's Clinical Hospital in Białystok.

SuppliesEU fundedElectronic submission

Location

Białystok, Poland

Duration

24 MONTH

Category

Medicinal products

Award Criteria

Price

Deadline

Expired Aug 18, 2026

Procurement Details

Publication date
06 Jul 2026
Languages
Polish

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
466950-2026

Documents (1)

Procurement document 1

Similar tenders

Poland – Various medicinal products – Dostawa produktów leczniczych, nr PN-127/26/TM

Sep 7

Belgium – Various medicinal products – Leveren van paracetamol oplossing voor intraveneus gebruik voor de ziekenhuisapotheek

Aug 27

Belgium – Anaesthetics – LEVEREN VAN ROCURONIUM 50 MG/ 5 ML VOOR INTRAVENEUS GEBRUIK

Aug 25

France – Various medicinal products – FOURNITURE DE MEDICAMENTS RADIOPHARMACEUTIQUES (TEP et SCINTI) ______________________________________________________________________

Sep 10

Belgium – Medicinal products for the respiratory system – LEVEREN VAN PIRFENIDONE 267 mg en 801 mg (filmomhulde) tabletten

Sep 14

Norway – Medical equipments, pharmaceuticals and personal care products – 2801c Medicines infusion injection

Sep 17